Home › Stock analysis › BCTX
BriaCell Therapeutics (BCTX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
What changed since yesterday
- Closed at $3.40, -9.81% vs the prior close of $3.77.
- Volume 134.00K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BCTX slides 9.8% to $3.40, a 1-month low. Closed at $3.40, -9.81% vs the prior close of $3.77. Day range $3.39–$3.91, opened at $3.70.
Last close$3.40-9.81%
Day range3.39–3.91
Open3.70
Volume134.00K
52-week range2.60–14.68
Avg volume (20d)105.73K
BCTX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — BCTX slides 9.8% to $3.40, a 1-month low
- Closed at $3.40, -9.81% vs the prior close of $3.77. Day range $3.39–$3.91, opened at $3.70.
- Volume was 134.00K shares, 0.4x its 50-day average of 316.93K — lighter than usual.
- Price is -10.4% vs its 50-day average ($3.80) and -15.3% vs its 200-day average ($4.01).
- 52-week range $2.60–$14.68; today's close sits at 7% of that range, 76.8% below the 52-week high.
Oct 15, 2026 — BCTX rises 2.2% to $3.77
- Closed at $3.77, +2.17% vs the prior close of $3.69. Day range $3.70–$3.85, opened at $3.71.
- Volume was 34.50K shares, 0.1x its 50-day average of 320.57K — lighter than usual.
- Price is -0.7% vs its 50-day average ($3.80) and -6.6% vs its 200-day average ($4.03).
- 52-week range $2.60–$14.68; today's close sits at 10% of that range, 74.3% below the 52-week high.
Oct 14, 2026 — BCTX dips 0.5% to $3.69, 7 down days in a row
- Closed at $3.69, -0.54% vs the prior close of $3.71. Day range $3.67–$3.88, opened at $3.70.
- Volume was 50.30K shares, 0.2x its 50-day average of 322.45K — lighter than usual.
- Price is -2.7% vs its 50-day average ($3.79) and -8.9% vs its 200-day average ($4.05).
- 52-week range $2.60–$14.68; today's close sits at 9% of that range, 74.9% below the 52-week high.
- That makes 7 straight losses.
Oct 13, 2026 — BCTX slides 4.1% to $3.71, 6 down days in a row
- Closed at $3.71, -4.13% vs the prior close of $3.87. Day range $3.71–$3.87, opened at $3.85.
- Volume was 54.20K shares, 0.2x its 50-day average of 324.26K — lighter than usual.
- Price is -2.0% vs its 50-day average ($3.79) and -8.9% vs its 200-day average ($4.07).
- 52-week range $2.60–$14.68; today's close sits at 9% of that range, 74.7% below the 52-week high.
- That makes 6 straight losses.
Oct 12, 2026 — BCTX dips 1.0% to $3.87, 5 down days in a row
- Closed at $3.87, -1.02% vs the prior close of $3.91. Day range $3.86–$3.95, opened at $3.92.
- Volume was 24.30K shares, 0.1x its 50-day average of 325.01K — lighter than usual.
- Price is +2.4% vs its 50-day average ($3.78) and -5.5% vs its 200-day average ($4.09).
- 52-week range $2.60–$14.68; today's close sits at 11% of that range, 73.6% below the 52-week high.
- That makes 5 straight losses.
Oct 9, 2026 — BCTX ends flat (-0.3%) to $3.91, 4 down days in a row
- Closed at $3.91, -0.26% vs the prior close of $3.92. Day range $3.91–$4.00, opened at $3.95.
- Volume was 23.30K shares, 0.1x its 50-day average of 325.98K — lighter than usual.
- Price is +3.7% vs its 50-day average ($3.77) and -4.9% vs its 200-day average ($4.11).
- 52-week range $2.60–$14.68; today's close sits at 11% of that range, 73.4% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — BCTX dips 2.0% to $3.92, 3 down days in a row
- Closed at $3.92, -2.00% vs the prior close of $4.00. Day range $3.87–$4.05, opened at $4.05.
- Volume was 48.70K shares, 0.1x its 50-day average of 325.93K — lighter than usual.
- Price is +4.1% vs its 50-day average ($3.76) and -5.3% vs its 200-day average ($4.14).
- 52-week range $2.60–$14.68; today's close sits at 11% of that range, 73.3% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — BCTX dips 0.5% to $4.00
- Closed at $4.00, -0.50% vs the prior close of $4.02. Day range $3.91–$4.10, opened at $4.00.
- Volume was 84.40K shares, 0.3x its 50-day average of 325.26K — lighter than usual.
- Price is +6.6% vs its 50-day average ($3.75) and -4.0% vs its 200-day average ($4.17).
- 52-week range $2.60–$14.68; today's close sits at 12% of that range, 72.8% below the 52-week high.
Oct 6, 2026 — BCTX slides 3.8% to $4.02
- Closed at $4.02, -3.83% vs the prior close of $4.18. Day range $3.99–$4.23, opened at $4.20.
- Volume was 69.10K shares, 0.2x its 50-day average of 324.80K — lighter than usual.
- Price is +7.4% vs its 50-day average ($3.74) and -4.1% vs its 200-day average ($4.19).
- 52-week range $2.60–$14.68; today's close sits at 12% of that range, 72.6% below the 52-week high.
Oct 5, 2026 — BCTX jumps 3.5% to $4.18
- Closed at $4.18, +3.47% vs the prior close of $4.04. Day range $3.94–$4.22, opened at $4.04.
- Volume was 59.40K shares, 0.2x its 50-day average of 324.89K — lighter than usual.
- Price is +12.0% vs its 50-day average ($3.73) and -0.8% vs its 200-day average ($4.21).
- 52-week range $2.60–$14.68; today's close sits at 13% of that range, 71.5% below the 52-week high.
Oct 2, 2026 — BCTX dips 1.7% to $4.04
- Closed at $4.04, -1.70% vs the prior close of $4.11. Day range $4.01–$4.33, opened at $4.17.
- Volume was 104.90K shares, 0.3x its 50-day average of 323.53K — lighter than usual.
- Price is +8.6% vs its 50-day average ($3.72) and -4.6% vs its 200-day average ($4.24).
- 52-week range $2.60–$14.68; today's close sits at 12% of that range, 72.5% below the 52-week high.
BCTX latest news & SEC filings
Every SEC filing by or about BCTX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Jun 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade BCTX
- Last results release: Oct 28, 2022 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 2.82% (largest 9.8%).
- Liquidity: about 105.73K shares (≈$359.47K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.40 vs a range of $2.60–$14.68 (7% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Aug 25, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Jun 26, 2026; 10-Q Jun 9, 2026; 8-K Jun 3, 2026.
- Share count: 8.70M shares outstanding (Jun 9, 2026), +28.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
BCTX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.70 | 3.91 | 3.39 | 3.40 | 134.00K |
| Oct 15, 2026 | 3.71 | 3.85 | 3.70 | 3.77 | 34.50K |
| Oct 14, 2026 | 3.70 | 3.88 | 3.67 | 3.69 | 50.30K |
| Oct 13, 2026 | 3.85 | 3.87 | 3.71 | 3.71 | 54.20K |
| Oct 12, 2026 | 3.92 | 3.95 | 3.86 | 3.87 | 24.30K |
| Oct 9, 2026 | 3.95 | 4.00 | 3.91 | 3.91 | 23.30K |
| Oct 8, 2026 | 4.05 | 4.05 | 3.87 | 3.92 | 48.70K |
| Oct 7, 2026 | 4.00 | 4.10 | 3.91 | 4.00 | 84.40K |
| Oct 6, 2026 | 4.20 | 4.23 | 3.99 | 4.02 | 69.10K |
| Oct 5, 2026 | 4.04 | 4.22 | 3.94 | 4.18 | 59.40K |
| Oct 2, 2026 | 4.17 | 4.33 | 4.01 | 4.04 | 104.90K |
| Oct 1, 2026 | 4.31 | 4.31 | 4.11 | 4.11 | 61.50K |
| Sep 30, 2026 | 4.08 | 4.34 | 4.01 | 4.28 | 88.00K |
| Sep 29, 2026 | 4.20 | 4.20 | 3.97 | 4.08 | 181.80K |
| Sep 28, 2026 | 4.21 | 4.40 | 4.01 | 4.16 | 293.40K |
| Sep 25, 2026 | 4.34 | 4.37 | 4.17 | 4.32 | 140.00K |
| Sep 24, 2026 | 4.08 | 4.43 | 3.99 | 4.28 | 241.70K |
| Sep 23, 2026 | 4.01 | 4.18 | 3.98 | 4.01 | 64.80K |
| Sep 22, 2026 | 4.15 | 4.37 | 3.92 | 4.09 | 188.60K |
| Sep 21, 2026 | 4.16 | 4.22 | 4.03 | 4.15 | 167.60K |
About BriaCell Therapeutics
BriaCell Therapeutics (BCTX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in WEST VANCOUVER, British Columbia, Canada. State of incorporation: British Columbia, Canada. Fiscal year ends July 31. SEC CIK 1610820.
BCTX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BCTX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jul 31, 2025 | — | $-26.31M | -62.19 | $-28.17M |
| Jul 31, 2024 | — | $-4.79M | -43.68 | $-24.13M |
| Jul 31, 2023 | — | $-20.30M | -1.30 | $-23.74M |
| Jul 31, 2022 | — | $-26.84M | -1.73 | $-12.48M |
| Jul 31, 2021 | — | $-13.82M | — | $-7.75M |
Latest balance sheet: total assets $27.07M, total liabilities $—, cash $6.88M (as of Apr 30, 2026).
BCTX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 28, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BCTX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.